For cell viability, we found that tumor cell viability of MGLH was significantly lower than that of LH (Figure S2F, 32.93 ± 12.52% versus 84.28 ± 15.53%, p = 0.0329), indicating a higher anticancer efficacy of MGLH. This evidence concerns the gene PLOD1 and neoplasm.